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Chest pain and ischaemic heart disease (IHD) are common presentations to 
Emergency Departments worldwide. Chest pain has a large differential 
diagnosis – from serious (myocardial infarct, pulmonary embolism, aortic 
dissection, etc.) to minor illness (gastric reflux disease), with the challenge of 
these presentations being to identify the cause of the chest pain concerned. It 
is often difficult to distinguish between those patients in whom ischaemia is 
the likely cause, and who require admittance and further examination, and 
those in whom the pain is unlikely to be caused by ischaemia. 
 
Approximately 25% of presentations fall into the first category (likely due to 
ischaemia, based on Electrocardiogram and clinical criteria). Of the 
presentations, 50% fall in a category in which ischaemia is unlikely to be the 
cause, leaving about 25% of the patients for whom the cause of pain is 
uncertain (Schaer [1]). If the last category is admitted and investigated, the 
chance of missing a deadly ischaemic event would be small, though the cost 
of admittance and medical examination would be very high. 
 
This study examines the outcomes of a group of low-risk patients with 
uncertain diagnosis, who were seen at a rural health facility. A stress ECG 
was performed on the patients within 24 hours of the onset of pain, with those 
with negative tests subsequently being discharged. 
 
 
1.2 Chest pain: The extent of the problem 


















non-cardiac type) are admitted to hospitals at a cost of $8 billion annually 
(Eslick [2]; Cannon [3]). In total, 1.68 million of the patients had acute 
coronary syndrome (ACS), of which one-quarter presented with acute 
myocardial infarction (AMI), with ECG ST segment changes and three-
quarters (±1.3 million) with unstable angina / non-ST segment changes 
(Eslick [2]; Cannon [3]). 
 
Australia 
In Australia, according to the Australian Institute of Health and Welfare, 
1 446 023 patients were admitted to hospital with IHD from 1998 to 
2007 (International Classification of Diseases [ICD] I20–I25: 945 101 
men, 500 922 women) (Cardiovascular disease [4]). 
 
Cardiovascular disease in Australia: a snapshot, 2004–2005, published by 
the Australian Bureau of Statistics, states that, 
despite steady improvement over the last three decades, cardiovascular 
disease remains one of the biggest causes of death in Australia and 
continues to generate a considerable burden on the population in terms 
of illness and disability... Cardiovascular disease is the most expensive 
health condition, costing 11%, or 5.4 billion Australian dollars, of the 
total allocated health system expenditure in 2000–01. (Cardiovascular 
disease [4]) 
 
In Australia, in 2007, IHD ICD 20 to ICD 25 was the leading underlying 
cause of death in the case of 22 729 (16%) registered deaths. IHD had been 
the primary cause of mortality for the previous 10 years, although deaths due 
to the disease had been declining (from 28 299 in 1998 to 22 729 in 2007), 
(Causes of death [5]). 
 
South Africa  
As this dissertation is for a South African university, the literature review 
includes statistics from South Africa. Also, similarly to Australia, South 
Africa has a rural population that is often some distance from tertiary medical 















According to Commerford et al. [6], 
[r]eliable statistics on health, life-expectancy and disease incidence in 
Africa are not readily available. The WHO 2007 report ranks the quality 
of cause-of-death information for most of Africa as low or non-existent. 
In this regard, Africa does not compare well to the rest of the world, and 
for much of Africa there is no information. The poor quality of the 




In Heart disease in South Africa Steyn et al. state that no data exist on the 
number of heart attacks or strokes that occur in South Africa, though, between 
1997 and 2004, 195 people died per day in the country due to some form of 
cardiovascular disease (CVD). During the years specified, on average 33 
people died of myocardial infarctions and approximately 60 of 
cerebrovascular incidents per day. For every female myocardial death, there 
were two male myocardial deaths (Steyn [7]; Bradshaw [8]). 
 
In South Africa, deaths before the age of 65 have a significant impact on 
economic activity. More than 50% of deaths resulting from chronic (including 
heart) disease were found to occur before the age of 65 years (Steyn [7]; 
Bradshaw [9]; Pestana [10]). 
 
In the working age group (34–66 years) CVD disease deaths are expected to 
increase by 41% between 2000 and 2030, resulting in widespread economic 
impact (Steyn [7]; Leeder [11]). 
 
In South Africa, the highest mortality rates due to CVD are found among 
those of Indian descent, followed by coloured, white and black people, with 
the last-mentioned having the lowest rates. Although the mortality rates from 
CVD for the white and black communities are similar, the specific CVDs 
differ. For white people, the disease tends to be myocardial infarction and for 
black people, the disease tends to consist of cerebrovascular incidents, 

















IHD has been in decline in the western/developed world, as the Australian 
Bureau of Statistics showed in its Causes of death [5]. In the United States, 
from 1994 to 2004 mortality rates due to CVD (ICD-10 I00–I99) declined 
24.7%, whereas during the same ten-year period, the number of actual CVD 
deaths declined by only 8% (Rosamond [13]). 
 
From the above, it is clear that IHD is still a major health problem. Not only 
does it cause widespread morbidity and mortality, but it also has significant 
economic implications both for health budgets and for the economy in 
general. It is also clear that EDs (including rural and remote departments), 
being the main points of entry for people with chest pain, will, in the 
foreseeable future, need to cope with ever-growing numbers of patients 
presenting with chest pain. It is expected that the departments concerned will 
make accurate diagnoses without unnecessary delays and in the most cost-
effective way possible. 
 
1.3 Risk scores and guidelines for diagnosis 
As mentioned below, in “Relevance and limitations of the stress ECG (1.6)”, 
approximately 25% of patients with chest pain tend to fall in a grey area, and 
require more detailed examination to exclude the possibility of coronary 
artery disease (Schaer [1]). 
 
Boufous et al. state that two-thirds of patients presenting with chest pain are 
admitted to hospital, only 15% of whom have confirmed AMI [Boufous [14]; 
Lee [15]). Of the patients discharged from the EDs, an estimated 5% might 
have a missed AMI, with an associated four times greater mortality (Herren 
[16]). 
 
Ramsay et al. [17], in their paper comparing risk scores, ask whether clinical 
features are sufficient for risk stratification. He states that (in relation to 
ACSs) the following holds: 
 Low diagnostic accuracy is achieved when diagnosis is based 















 Chest pain of atypical distribution may indicate a myocardial 
infarction (Goodacre [20]).Up to a third of patients who 
develop myocardial infarct do not suffer from typical chest 
pain. 
 Less than half of those admitted with chest pain have ACSs 
confirmed at discharge (Blatchford [21]),
 
and up to 6% of 
those discharged from hospital have a missed myocardial 
infarction
 
(Collinson [22]; which is 1% more than Boufous et 
al. found, as stated above). 
 
Risk stratification can be employed to improve diagnostic accuracy and to 
reduce the number of hospital admissions and attendant costs. There are many 
risk scores, such as GRACE (Global Registry of Acute Coronary Events), 
TIMI (Thrombolysis in Myocardial Infarction), and PURSUIT (Receptor 
Suppression using Integrillin). According to De Araujo, GRACE is better at 
accurate prediction in an ACS population than is either TIMI or PURSUIT 
(De Araujo Goncalves [23]). Ramsay et al. [17] found that, in patients with 
suspected cardiac pain in an unselected population, the GRACE risk score is 
superior to the TIMI risk score and the use of either is better than using ECG 
and troponin (TNI) testing at presentation. It is clear from the above that 
some form of risk stratification is needed when evaluating a chest pain patient 
in an ED. 
 
In Australia, the National Health and Medical Research Council (NHMRC), 
with the aim of reducing the risk of missing AMIs and of decreasing the 
number of unnecessary hospital admissions, recommends the use of 
guidelines, including risk stratification algorithms based on risk scores 
(Diagnosis and management [24]). The combined application of management 
strategy and risk stratification is emerging as a new approach to patients with 
chest pain, rather than merely as a form of establishing a diagnosis (Nichol 
[25]; Lee [26]). 
 














[27]), Boufous et al.[14], in Impact of a chest pain guideline on decision 
making, concluded that following guidelines resulted both in a significant 
improvement of clinical decision-making in EDs and in reduced repeat 
presentation with real or potential cardiac chest pain. 
 
The Queensland Health Guidelines, as taken from the Guidelines for the 
management of acute coronary syndromes 2006 by the National Heart 
Foundation of Australia and the Cardiac Society of Australia and New 
Zealand (Constantine [28]); (cf. section 2.6 below), are used in the current 
chart audit. The Guidelines seem at least partially, for the intermediate-risk 
group, to be based on the TIMI risk score. 
 
1.4 Stress-testing modalities 
Stress-testing modalities are included in the recommendations of the 
American College of Cardiology and of the American Heart Association for 
the diagnosis and risk stratification of patients with known or suspected IHD. 
 
The following modalities are described in “Advantages and limitations of 
different stress-testing modalities” by D.A. Weiner et al. [29] in Up to date:  
 treadmill exercise electrocardiography (which is discussed in 
 more detail below) 
 exercise radionuclide myocardial perfusion imaging 
 exercise radionuclide angiography 
 exercise echocardiography 
 
Pharmacologic stress 
Pharmacologic stress testing is performed either with dipyridamole or 
adenosine, or by means of dobutamine echocardiography. 
 
The advantages of treadmill electrocardiography are as follows: 
 The equipment is widely available and the cost is low. 
 The accuracy has been proven with different populations (132 
studies / 24 000 patients), (Gianrossi [30]). 














functional capacity and prognosis (Garber [31], Gibbons [32], 
Gibbons [33]). 
 The equipment is widely available. 
 The accuracy of the test has been tested in different populations. 
 
 
The disadvantages of treadmill electrocardiography are as follows: 
 The sensitivity is lower than with the stress imaging test (Garber 
[31]). 
  A resting ECG with marked ST-T abnormalities will have poor 
specificity on stress ECG, for example with: 
– the use of digoxin (Gibbons [32]); 
– the left bundle branch block (LBBB), (Gibbons [32]); 
– pacemakers (Gibbons [32]); or 
– patients of the female gender (Morise [34], Melin [35]). 
There is also an inability to localise the extent of the 
myocardial ischaemia, if performed post-revascularisation 
(Kafka [36]). 
 
According to San Roman et al., myocardial imaging with Sestamibi was 
found to have the greatest sensitivity, while echocardiography was found to 
have the greatest specificity. However, all four stress modalities were found 






























































    
Positive 91 96 92 85 
Negative 49 73 69 72 
 
For the sake of completeness, the other modalities mentioned are briefly 
discussed below. 
 
Exercise radionuclide myocardial perfusion imaging 
Exercise radionuclide myocardial perfusion imaging uses a radioactive drug 
to evaluate the coronary blood flow. This drug is spread throughout the heart 
muscle, proportional to the coronary artery blood flow.  
 
Exercise radionuclide myocardial perfusion imaging has the following 
advantages: 
 the ability to detect CAD and to assess prognosis once confirmed; 
 reproducible results; 
 the qualitative assessment of left ventricular function (DePuey 
[38]); 
 improved sensitivity and specificity; 
 improved determination of the extent of coronary disease and the 
prognosis thereof; and 
 the ability to assess myocardial function. 
 
The exercise radionuclide stress test presents the following problems: 
 It is expensive. 
 It takes longer, and allows for the risk of exposure to radiation, 
although in small amounts. 
 Purposely trained readers and good quality control of the 














 Artefacts may be due to soft tissues, such as that of the breast, or 
signal attenuation, caused by the use of a diaphragm. 
 LBBB leads to false positive results and low specificity 
(Tawarahara [39]). 
 
Isotopes used with the radionuclide stress imaging 
The following isotopes are used with the radionuclide stress imaging: 
 The properties and actions of thallium are as follows: 
– Thallium-201 is a radioactive atom. 
– Thallium myocardial uptake is proportional to flow (Strauss 
[40]), Nielsen [41]). 
– One injection of thallium-201 can be used both for stress and 
for resting images, due to its redistribution characteristics 
(Pohost [42]).  
– Thallium has been validated more extensively for finding 
viable myocardial muscle (Steien [43]). 
 
 The properties and actions of sestamibi (with Tc 99m sestamibi 
falls into the isocyanide [isonitriles] class of compounds) are as 
follows: 
– It has the potential of measuring the resting left ventricular 
ejection fraction (DePuey [38]). 
– Myocardial uptake is proportional to flow (Glover [44]). 
– There is minimal redistribution over time, giving greater 
flexibility in planning, because imaging is not necessary 
immediately after injection. It also fits the long acquisition 




Exercise echocardiography has the following advantages (Gibbons [33], 
Fleisher [46], Kafka [36]): 















 It provides details of the presence and extent of myocardial 
ischaemia. 
 The results are immediately available. 
 The ultrasound machine and treadmill are portable. 
 It takes less time, and is not as expensive as, exercise nuclear 
imaging. 
 It allows for ventricular function, chamber size, wall thickness and 
valvular function to be evaluated. 
 It can be used to diagnose ischaemia in cases of baseline ECG 
abnormalities. 
 
The disadvantages of echocardiography include the following (Gibbons [33], 
Fleisher [46], Kafka [36]): 
 Because it is operator-dependent, the interpretation is subjective 
and not standardised. 
 Resting wall motion abnormalities make interpretation 
problematic. 
 Often poor image quality leads to non-diagnostic stress testing. 
 Because the echocardiographic stress test is relatively new, it is 
uncertain whether it can be used for prognosis. 
 Current guidelines do not recommend the use of exercise 
echocardiography with patients with LBBB or paced ventricular 
rhythm, due to the limited number of studies that have been 
undertaken so far in this regard. 
 
When a patient cannot exercise, pharmacologic stress testing is possible. 
Dipyridamole or adenosine is used in radionuclide myocardial perfusion 















The properties and actions of the drugs are as follows. 
 The properties and actions of adenosine are as follows:  
– It is a naturally occurring substance present throughout the 
body, with the function of regulating the blood flow in 
various vascular beds (Akinpelu [47]). 
– Adenosine activates the A1 and A2 receptors (primarily the 
latter) on the cell surface, which leads to an increase in the 
cyclic adenosine monophosphate (cAMP), with such an 
increase leading to an inhibition of calcium uptake by the 
sarcolemma in the smooth muscle resulting in relaxation and 
vasodilatation. The relaxation and vasodilatation is 
attenuated in diseased coronary vessels. Due to such vessels 
having a reduced coronary flow reserve, they cannot dilate 
further in response to adenosine. The result is heterogeneity 
in the blood flow, with healthy and less diseased vessels 
receiving more coronary blood flow than do their diseased 
counterparts (Akinpelu [47]).  
– Usually, coronary blood flow does not decrease in the 
diseased vessels, though, in cases of severe stenosis or total 
occlusions with compensatory collateral flow, a decrease in 
blood flow may occur with adenosine, thus resulting in the 
coronary steal syndrome (Akinpelu [47]). 
 
 Dipyridamole works by increasing intravascular adenosine levels. 
It does this by stopping the reuptake and deamination of 
adenosine. In both cases, a radiopharmaceutical is then injected to 
visualise the heterogeneity in the coronary blood flow (Akinpelu 
[47]). 
 
 Dobutamine is a synthetic catecholamine that stimulates β1 and 
β2 receptors, leading to an increase in heart rate, blood pressure, 
and myocardial contractility, thus increasing the regional 
myocardial blood flow, based on physiological principles 














Dipyridamole and adenosine have the following advantages: 
 They enable those patients who are unable to exercise to be 
assessed accurately for ischaemia, with preoperative risk 
assessment in patients with claudication or musculoskeletal 
problems being examples of such assessment (Akinpelu [47]). 
 They are safe for use with selected patients and, if side-effects 
occur, they can be reversed by stopping the administration of the 
dipyridamole or adenosine, or by administering aminophylline 
(Akinpelu [47]). 
 They are more specific than is exercise perfusion imaging in 
patients with coronary disease and LBBB (Akinpelu [47]). 
 
The following problems are present with the use of dipyridamole: 
 Functional capacity cannot be evaluated. 
 Exercise testing has a greater chance of detecting ECG 
abnormalities (Akinpelu [47]). 
 It cannot be used in the case of any of the following: hypotension, 
sick sinus syndrome, high-grade heart block (in the absence if 
pacemakers), or asthma. Patients on oral dipyridamole cannot be 
tested, and theophylline and caffeine intake must be stopped 
before testing (Akinpelu [47]). 
 Efficacy of medical treatment cannot be assessed by means of 
repeated pharmacologic stress testing (Akinpelu [47]). 
 The coronary steal phenomenon may be caused by the use of 
dipyridamole (in about 45% of patients) with severe coronary 
heart disease (Akinboboye [48]).The steal phenomenon can cause 
subendocardial ischaemia, according to Dahlberg and Leppo:  
Overall, these studies of regional coronary flow suggest that 
several physiologic mechanisms for ischemia with 
vasodilators are possible. One important implication is that 
myocardial segments (especially in the subendocardium) may 
experience an absolute decrease in blood flow that results in 














regional transmural blood flow. It is also evident that an 
ischemic ECG response during vasodilator stress is often 
associated with multivessel coronary disease that has led to 
collateral development (Dahlberg [49]).
 
 The specificity is lower in the presence of a right ventricular 
pacemaker (Skalidis [50]). 
 
Dobutamine echocardiography 
Dobutamine echocardiography has the following advantages (Marcovitz [51], 
Salustri [52], Gibbons [53]): 
 Patients unable to exercise can be accurately assessed for 
ischaemia. 
 It accurately identifies the threshold of myocardial ischaemia and 
the myocardial viability concerned. 
 Similarly to exercise stress echocardiography, it measures several 
parameters, such as total and regional ventricular function, 
chamber size, wall thickness and valvular function. 
 In patients with LBBB, the specificity is higher in regards to 
finding coronary disease than it is in exercise perfusion imaging 
(Cortigiani [54]). 
 
The following problems exist with dobutamine echocardiography (Marcovitz 
[51], Salustri [52], Gibbons [53]): 
 It cannot measure functional capacity. 
 ECG abnormalities are more likely to occur in exercise testing. 
 In obese patients and those with chronic obstructive pulmonary 
disease, it may be difficult to obtain a good echocardiographic 
window. 
 A highly skilled and experienced operator is needed for the 
application. 
 It is time-consuming. 
 In patients with poor left ventricular function and severe CAD, 














 In the case of symptomatic aortic aneurism, it is contraindicated. 
 
In a meta-analysis comparing the different chemical stressors (adenosine, 
dobutamine and dipyridamole), Kim et al. [55] found that adenosine (89%) 
and dipyridamole (90%) perfusion imaging had the highest sensitivity, 
dipyridamole echocardiography had the highest specificity (93%), and 
dobutamine echocardiography had the best combination of sensitivity (80%) 
and specificity (84%). 
 
1.5 Description and purpose of the stress ECG exercise tolerance test (ETT) 
In 1928, Feil and Seigel [56] first reported ST and T changes following 
exercise in three patients with chronic stable angina. In 1929, Master and 
Oppenheimer [57] introduced a standardised exercise protocol to access 
functional capacity and haemodynamic response.
 
  
Patients with IHD may have a normal ECG at rest. Exercise may induce 
ischaemia if the presence of CAD limits flow such that it is insufficient to 
meet myocardial oxygen demand. This may result in ECG changes, which 
most commonly take the form of ST segment depression. The modern stress 
ECG consists of graded treadmill exercise, entailing constant monitoring of 
the 12-lead ECG. It is used both for diagnosis and prognosis. 
 
According to Hill and Timmis, [58] the ETT can be used in the following 
instances: 
 For the following diagnostic indications: 
– assessment of chest pain in patients with intermediate 
probability of CAD; 
– arrhythmia provocation; and 
– assessment of symptoms (e.g. pre-syncope) occurring during 
or after exercise (Hill [58]). 
 
 For the following prognostic indications: 
– risk stratification after myocardial infarction; 















– evaluation of revascularisation or drug treatment; 
– evaluation of exercise tolerance and cardiac function; 
– assessment of cardiopulmonary function in patients with 
dilated cardiomyopathy or heart failure; and 
– assessment of treatment for arrhythmia. 
 
The Bruce Protocol for ETT is the most widely used, and has been 
extensively validated. It has seven stages of three minutes each (amounting to 
a total of 21 minutes), (Bruce [59]). The patient starts at 2.7 km, with 10% 
incline, and the speed and incline is increased with each stage. 
 
A modified Bruce Protocol may be used in patients after the myocardial 
infarction. For diagnostic testing, patients are requested to stop taking 
medications, such as beta-blockers (β-blockers) and digoxin, which might 
influence the ETT. 
 
ECGs conducted while sitting, standing and hyperventilating are done to rule 
out possible artefacts due to change(s) in position (such as varying sitting 
with standing), motion and pH changes (such as with hyperventilation). 
 
The ETT machine monitors the heart rate continuously and a 12-lead ECG is 
recorded intermittently (though sometimes continuously, depending on the 
equipment used). Blood pressure is also monitored during the test (Hill [58]). 
The test must be supervised by a clinician who is experienced in 
resuscitation, who has a full range of resuscitation equipment available.  
 
Workload and maximum heart rate are also measured during an ETT. 
Workload is measured in metabolic equivalents (METs). The METs, starting 
at 2.7 km/h with a 10% incline, should be 4.8. Workload is an indication of 
oxygen consumption, and hence energy use. The formula in this respect is as 
follows: 
1 MET = 3.5 ml oxygen per kg/min 

















Conventionally, the maximum predicted heart rate is taken to be 220 in men 
and 210 in women, minus the age of the patient. Note worthily, Robergs et al. 
[60] state: 
This equation is often presented in textbooks without explanation or 
citation to original research. In addition, the formula and related 
concepts are included in most certification exams within sports 
medicine, exercise physiology, and fitness. Despite the acceptance of 
this formula, research spanning more than two decades reveals the 
large error inherent in the estimation of HRmax (Sxy = 7–11 b/min). 
Ironically, inquiry into the history of this formula reveals that it was not 
developed from original research, but resulted from observation based 
on data from approximately 11 references consisting of published 
research or unpublished scientific compilations. Consequently, the 
formula HRmax = 220 − age has no scientific merit for use in exercise 
physiology and related fields.
 
 
A satisfactory response is achieved when 85% of the predicted maximum 
heart rate is achieved. A good prognostic sign is the reaching of maximum 
heart rate and stage III of the Bruce Protocol. 
 
1.6 Relevance and limitations of the stress ECG 
The ETT has a sensitivity of 78% and specificity of 70% for finding IHD in 
western populations with high prevalence of the disease. This means that it 
cannot, on its own, be used to rule out the presence of IHD. The chance of 
having IHD has to be taken into consideration. In low-risk patients, such as in 
men who are younger than 30 and in women who are younger than 40 
(according to Hill and Timmis [58], Fleisher [46], Gibbons [33]), a positive 
test is likely to be falsely positive, and in high-risk populations, namely those 
of 50 years and older, with chest pain, its presence cannot be ruled out on a 
negative test. 
 














and the prevalence of IHD in the population being tested. The likelihood of 
obtaining a false positive test is the highest in the case of those with the 
lowest pre-test probability of the disease, namely in women, young people 
and those in populations with a low prevalence of IHD. 
 
The attainment of a high workload without symptoms and ECG changes 
makes the presence of significant obstructive coronary disease unlikely. 
However, the attainment of a high workload in the case of a high-risk 
individual does not exclude the development of ACS, as, in such a case, 
infarction may still result from the rupture of a previously non-occlusive 
unstable plaque. The ETT has its greatest diagnostic use with the middle-risk 
group of patients. 
 
Depression of the ST segment is often used as the most important indicator of 
myocardial ischaemia. However, Hill and Timmis [58] remind us that such an 
indicator is limited in its usefulness. ST depression occurs in up to 20% of 
normal people with ambulatory ECGs, as many other causes apart from IHD 
serve to depress the ST segment. Such causes include repolarisation and 
conduction disorders, such as LBBB, pre-excitation, and the effect of such 
drugs as digoxin. 
 
Though the above might lead to the conclusion that ETT is limited in its 
usefulness in ruling IHD in or out, the following factors need to be 
considered: 
Patients with acute chest pain represent up to 20% of emergency 
hospital admissions, with an estimated > 5,7 million visits per year in 
the United States alone. In approximately 25% of these visits AMI with 
typical ECG changes and/or cardiac enzymes rise is diagnosed. In 50% 
of these visits CAD can be ruled out based on history, clinical 
examination, ECG findings and serial cardiac markers (Schaer [1].)
 
 
This leaves approximately 25% of patients in a grey area, requiring further 
















The determination of the disposition of patients with chest pain with normal 
ECGs or no ST segment elevation, and with no TNI rise in ED, is difficult, 
time-consuming and confusing. According to Sanchis et al. [61], “[d]ecision-
making and risk stratification for patients with acute chest pain, non-




Sanchis et al. concluded that chest pain patients with normal ECGs, or with 
no ST segment elevation and no TNI rise, showed a non-negligible rate of 
events in one year, and derived a risk score for that specific population that 
allowed for a more accurate stratification than was obtained with use of the 
TIMI risk score (Sanchis [62]).The risk score included early stress testing. 
 
The European Cardiology Society Task Force recommends performing a 
stress test before discharging the patient when severe diseases, such as aortic 
dissection and pulmonary embolism, have been ruled out, and no chest pain 
symptoms have occurred for a period of six hours (Erhardt [63]). Combined 
with clinical criteria, stress testing permits acceptable risk stratification 
(Atman [64], Sanchis [65], Lauer [66]).  
deFilippi et al. [67] conclude that in low-risk patients a strategy of using 
coronary angiography (CA) has the capacity to detect more CAD than ETT, 
reducing the need for long-term ED and hospitalisation, and yielding 
improved patient satisfaction and understanding of their condition. However, 
the problem is that, 
for low-risk patients, CA may not be practical at many institutions, 
because it is not widely available on an immediate basis for non-
emergency use. The invasive nature of this procedure will also limit its 
acceptance for this indication. Current guidelines recommend symptom-
limited ETT during the initial [chest pain unit] CPU assessment and the 
consideration of CA in repeat presenters with previous negative cardiac 


















myocardial ischaemia detected by ETT, in the sense that CA identifies the 
presence of anatomical disease in large vessels, whereas ETT examines the 
effects of the anatomical disease. Ischaemia may be present in the absence of 
anatomical large vessel disease, as in the case of ‘Syndrome X’. 
 
1.7 Conclusion  
The literature shows that IHD and chest pain are common problems 
presenting to EDs. Although there is a decline in the numbers of patients 
presenting with the disease, it is still a significant and costly problem in the 
western world and is on the rise in the developing world. 
 
With one category of patients it is difficult either to confirm or to refute the 
presence of IHD without the use of costly invasive measures. Together with 
risk stratification, ETT can be used to differentiate between those patients 
who warrant further investigation and those who can safely be discharged. 
  
1.8 Purpose of the study 
The challenge of ruling out IHD becomes ever more difficult the further that 
one is from large metropolitan cities and tertiary medical centres. Rural 
doctors and emergency physicians working in remote EDs have to send their 
potential IHD patients to bigger centres for the ruling in or out of disease, 
which is a time-consuming and costly practice, and which might even lead to 
a delay in diagnosis and treatment.  
 
Therefore the purpose of the current study is to answer the question whether 
it is possible for the rural EDs to rule out IHD with a relative degree of 
certainty and safety in patients, employing the patients’ history, a clinical 

















STUDY DESIGN & METHODS 
2.1 Description of Rockhampton Base Hospital  
Rockhampton Base Hospital is a public hospital serving a community of 
approximately 120 000 people in central Queensland, Australia. It has general 
physician cover and a coronary care unit (CCU), but, until three months ago, 
had no cardiology cover. The CM unit of the hospital conducts stress ECGs 
for the hospital patients, as well as for patients referred by the local general 
practitioners. Due to the large demand for stress ECGs, the CM unit has 
difficulty in coping with the workload, with it taking from six months to a 
year for an outpatient (referred by a general practitioner) to have his/her stress 
ECG performed. 
 
The hospital has no intervention suite for angiography or PCI. All patients 
requiring such examination are, therefore, sent to Brisbane (the capital of the 
state of Queensland, 650 km from Rockhampton) for further diagnosis and 
treatment. An MPS is available at Rockhampton’s private hospital. 
 
Rockhampton’s ED annually sees about 40 000 (39 599 from 01-06-07 to 31-
05-08) patients, of which 1 599 presented with chest pain or ACS, with 611 
being admitted (EDIS [68]), 
 
(ICD codes I20.0–I25.9 and R07.1–R07.4). 
 





2.2 Study design 
Between 27-04-06 and 23-04-08, the Rockhampton ED conducted stress 
ECGs for 331 patients with low-risk features, as per the Queensland Health 
Protocol (see below). The retrospective study took the form of an audit of the 
charts of the patients concerned (who formed a convenient sample), with the 














and relatively reliable strategy for use with such patients. 
 
2.3 Subject selection 
The Clinical Measurements Department keeps records of all the ETTs 
conducted by the Rockhampton ED. A list of names of patients who had ETTs 
done by the ED between the specified dates was obtained. 
 
The following 34 patients, whose names appeared on the list, were excluded 
from the study: 
 those patients not primarily seen by the ED; 
 those patients who were referred for ETT to the clinical 
measurement (CM) unit by the wards of Rockhampton Hospital, 
or by other hospitals, with the ETT being conducted by one of the 
emergency physicians; and 
 those patients with charts on which the necessary data were 
inadequately completed or missing. 
 
2.4 Retrospective data 
Since the chart audit was conducted retrospectively, the data were only as 
good as the notes of the attending physician and the quality if the ECG. 
 
2.5 Data collection 
A form was developed for the auditing of the charts. The current researcher, 
together with fellow ED doctors, reviewed the data on the charts, which were 
obtained from the Medical Records Department of Rockhampton Hospital. 
Approximately five doctors from other departments in the hospital, or from 
the ED itself, helped with the data collection. Some of the doctors may have 
been the treating doctors for the patients being evaluated, but, because of the 
high staff turnover, it is not possible to say whether any bias might have been 
present in the collection of the data. The audit was conducted in the computer 
room of the ED and in the medical library, so that the charts never left the 
hospital grounds. 
 














were obtained from the Auslab computer database of the Queensland Health 
Pathology Service by the current researcher, and from the EDIS computer 
database / management system program of the ED by those doctors working 
in the emergency unit who had password access to the systems involved. The 
data collected on the audit form were filed numerically and then entered onto 
the Excel
©
 computer database. 
 
2.6 Guidelines 
The guidelines used were those of the ‘Queensland Health Protocol for Risk 
Determination of Acute Coronary Syndrome’. The Protocol was taken from 
the Guidelines for management of acute coronary syndromes 2006 by the 
National Heart Foundation of Australia and the Cardiac Society of Australia 
and New Zealand (Constantine [28]).
 
 
The above-mentioned guidelines state that the two objectives in risk 
stratification are the following: 
 to define the likelihood of ACS as the reason for the patient’s chest 
pain; and 
 to determine the risk of short-term adverse outcomes, so that a 
management plan can be developed for the patient concerned. 
 
According to the specified guidelines, patients with ACS are likely to present 
with the classical picture being prolonged or recurrent central chest pain/ 
discomfort, although others, especially the elderly, diabetics and women, 
might present with atypical features. Atypical features are discomfort or pain 
in the neck, jaw, back or stomach, dyspnoea, diaphoresis, nausea and 
vomiting. 
 
Age is an important risk factor. In younger patients, the presence or absence 
of coronary risk factors is considered in full when making a diagnosis, but in 
the middle-aged and elderly such factors are of less use in diagnosis. 
 
A history of physical or emotional stress increases the likelihood of ACS 














The physical examination of patients with NSTEACS is usually normal, with 
the ECG indicating normal or minor changes in 50% of the cases. 
 
According to the guidelines, diabetes is an independent risk factor for adverse 
cardiac events. If patients have typical symptoms, diabetes should be 
regarded as a high-risk feature, with the risk being similar to that of an 
elevated TNI or ST segment deviation (Roffi [70], Cannon [71]). The 
guidelines state that the chance of undiagnosed diabetes presenting itself as 
ACS is quite high (Conaway [72]).
 
 
In chronic kidney disease, an increased risk of mortality, recurrent cardiac 
incidents and bleeding events in patients with a reduced renal function and 
ACS has been extensively documented (Gupta [73]). From the evidence, a 
glomerular filtration rate (GFR) of less than 60 ml/min has been found to 





High-risk features include presentation with clinical features consistent with 
ACS and any of the following (Constantine [28]): 
 repetitive or prolonged (> 10 min) ongoing chest pain or 
discomfort;  
 elevated levels of at least one cardiac biomarker (e.g. TNI or 
creatinin kinase MB fraction [CK-MB]); 
 persistent or dynamic ECG changes of ST segment depression 
equal to, or greater than, 0.5 mm, or new t-wave inversion equal 
to, or greater than, 2 mm; 
 transient ST segment elevation (equal to, or greater than, 0.5 mm) 
in more than two contiguous leads; 
 haemodynamic compromise with systolic blood pressure  
< 90 mmHg, cool peripheries, diaphoresis, *Killip Class > 1, 
and/or new onset mitral regurgitation; 















 left ventricular systolic dysfunction (left ventricular ejection 
fraction < 40%); 
 prior percutaneous coronary intervention (PCI) within six months, 
or prior coronary artery bypass surgery; 
 the presence of known diabetes (with typical symptoms of ACS); 
and 
 chronic kidney disease (estimated GFR < 60 ml/min; with typical 
symptoms of ACS). 
 
 
Killip classification (Killip [75]).
 
From a study undertaken at a university hospital in the United States of 
America (including 250 patients, from 24 to 94 years old, with a mean of 
64 years), the following nomographic  classification could be made: 
 
 Killip class I includes individuals with no clinical signs of heart 
failure. In the above-mentioned study, 81 (32% [27%–38%]) of 
the patients were found to fall in this class, with their mortality 
rate being found to be 6%. 
 
 Killip class II includes individuals with rales or crackles in the 
lungs, an S3 gallop, and elevated jugular venous pressure. In the 
above-mentioned study, 96 (38% [32%–44%]) of the patients were 
found to fall in this class, with their mortality rate being found to 
be 17%. 
  
 Killip class III describes individuals with frank acute pulmonary 
oedema. In the above-mentioned study, 26 (10% [6.6%–14%] of 
the patients were found to fall in this class, with their mortality 
rate being found to be 38%. 
 














hypotension (measured as systolic blood pressure lower than 
90 mmHg), and with evidence of peripheral vasoconstriction 
(oliguria, cyanosis or sweating). In the above-mentioned study, 47 
(19%[14%–24%]) of the patients were found to fall in this class, 
with their mortality rate being found to be 81%. 
 
Intermediate-risk features 
Intermediate-risk features include presentation with clinical features 
consistent with ACS and any of the following intermediate risk factors, as 
well as not meeting the criteria for high-risk ACS: (Constantine [28]) 
 chest pain or discomfort within the preceding 48 hours that 
occurred at rest, or which was repetitive or prolonged (but 
currently resolved);  
 age > 65 years; 
 known CAD, with prior myocardial infarction, with left 
ventricular ejection fraction equal or greater than 40%, or known 
coronary artery lesion greater than 50% stenosed; 
 no high-risk changes on the ECG (see above); 
 two or more of the following risk factors: 
– known hypertension; 
– family history; 
– active smoking; and/or 
– hyperlipidaemia; 
 the presence of known diabetes (with atypical symptoms of ACS); 
 chronic kidney disease (estimated GFR < 60 ml/min, with atypical 
symptoms of ACS); and/or  




Low-risk features presentation with clinical features consistent with ACS, in 
the absence of intermediate-risk or high-risk features. Such features include 
the onset of anginal symptoms within the preceding month, the worsening in 
















2.7 Audit form 
 The audit form, which was developed with the Queensland Health 
 Guidelines (Constantine [28]) in mind, reviewed the following: 
 risk, in terms of: 
– gender and/or age; 
– weight (obesity, if noted by attending physician on the day of 
the first presentation that incited the ETT); 
– hypertension and diabetes (as per medication taken, previous 
notes / medication chart); 
– first-degree family history (ACS in parents and siblings); 
– previous history of IHD (as per history noted by attending 
physician or notes/reports on chart) in the form of either 
angina or myocardial infarction; 
–  cardiopathology, such as myopathy (as per history noted by 
attending physician or notes/reports on chart); 
– currently smoking, or ex-smoker (as per history noted by 
attending physician or in notes/reports on chart); 
– hyperlipidaemia (as per history noted by attending physician 
or in notes/reports on chart, or drug chart); 
– renal disease (as per GFR < 60 on Auslab report); and/or  
– the presence of pain (as per history noted by attending 
physician), in terms of duration, frequency in the preceding 
48 hours; or absence of pain on presentation; 
 Transportation (as per notes/drug sheet obtained from the 
Queensland Ambulance Service [QAS]) by QAS or other, 
  with any of the following having been administered by the QAS: 
– morphine; 
– oxygen (O2); 
– aspirin; 
– glycerine trinitrate (GTN); and/or 
– other; 














(as per drug chart / notes on chart): 




– clopidogrel; or 
– other; 
 ECG (physically available on chart): 
– number of ECGs undergone prior to the administration of 
the stress ECG; 
– any ST segment changes; 
– narrow QRS complexes; 
– previous ECG on chart, indicating the possibility of IHD; 
and 
– post-event ECG indication that the patient visited the ED 
again with a complaint of chest pain; 
 chest X-ray (CXR) undertaken (as noted by the attending 
physician / reported on the chart); 
 TNI (as per Auslab record), considering the number of TNI tests 
done, at what time, and the value obtained; 
 the stress ECG (as per ETT noted on the chart), in terms of: 
– the time and date; 
– the workload achieved; 
– the percentage maximum heart rate achieved; and 
– a positive indication, in terms of: 
■ myocardial perfusion scan (MPS) (as per report on 
chart); 
■ angiography (as per report/notes on chart); and 
■ medical admit (as per notes on chart); 
– a negative indication (as per report/notes on chart); 
– an equivocal indication (as per report/notes on chart), in 
terms of: 














■ angiography (as per report/notes on chart); and 
■ medical admit (as per notes on chart); and 
 (Adverse reactions to the ETT would have been noted here in the 
medical notes) 
– Date of last visit to ED (as by Auslab/EDIS) 








 A questionnaire was developed by the current researcher, with the 
help of, and review by, Dr Thompson. 
 
The following questions were asked: 
 Have you had any chest pain or heart problems since your last 
visit to the Emergency Department? 
 If yes, did you have a heart attack/angiogram/MPS/other? 
 
From the questions the current researcher hoped to learn whether, if the patient 
had experienced more chest pain and/or heart problems after the ETT, there was 
still a recurring/persistent problem. 
 
The questions were asked in closed or forced format (providing a choice of 
categories), with: 
 the answers being quick and easy to fill in; 
 the questions minimising discrimination against the illiterate; 
 the answers obtained being easy to record in code, thus facilitating 
quantitative analysis of the results; and 
 the results being easy to report (Leung [76]). 
 














process of being evaluated for IHD. The question was asked in closed format (in 
terms of a differential scale) to give the current researcher an idea of how the 
patients felt about the process. It is understandable that the experience of chest 
pain can cause patients stress and fear. Consequently, the question was not 
intended to judge the medical correctness of the treatment, but rather to discover 
the experience of the patients of the service provided by the ED. (See Appendix 1 
for the questionnaire.)  
 
2.9 Ethical considerations 
The study, being a chart review, did not require patient consent. The 
questionnaire had the approval of the Ethics Committee of the University of 
Cape Town and of the director of the ED at Rockhampton Base Hospital. 
Patients’ charts never left the hospital grounds, and were only reviewed by 
medical staff employed by the hospital. All the data were kept on a password-
protected computer in a locked office. 
 
2.10  Outcomes to be measured 
The endpoint of the study for each patient concerned was likely to be one of the 
following:  
 alive and well, with no signs or symptoms of IHD by date of 
follow-up contact; 
 alive, but with IHD that developed post-stress ECG by date of 
follow-up contact; 
 dead from IHD; or 
 dead from another cause. 
The IHD was likely to have been diagnosed because the stress ECG was positive 
or equivocal, and had led to an MPS and/or angiography. 
 
Outcome 
The outcome of this study is expected to be confirmation that stress ECG is a 
safe and reliable option in EDs for those patients with risk-stratifying low-

















3.1 Data capture 
The data capture took the following form: 
 331 ETTs were done by the CM unit with the help of ED doctors. 
 297 audit sheets were entered into the audit. 
 34 audit sheets were rejected, due to the following reasons: 
– 15 were not primarily seen by Rockhampton ED, but were 
referred by draining hospitals. 
– 13 had so much data missing or such incomplete records that 
entry into the audit was impossible. 
– 6 had no chart available for audit. 
 All of the audit sheets were completed for the 297 charts, but 
many data points were marked as missing data, due to lack of 
information noted in the files. The extent of the missing data will 
be reported and discussed below. 
 
3.2 Basic patient demographics 
Table 3.1 below shows the basic gender distribution and age demographics of 
the patients on whom the audit was based. 
 
Table 3.1: Basic gender distribution and age demographics 
GENDER  AGE  
Total Male Female Mean ± STD* Median  Range 
297 179 118 50.198 ± 13.81 50 20–87 





Of the patients experiencing chest pain: 
 the median duration of pain was 45 minutes (with the SD being 
±702.15 min, or 11.7 h). 














when the chest pain started; and 
 158 (53.19%) patients still had pain on arrival, whereas 112 
(37.71%) were pain-free, as noted by the nurse in the patient’s 
observation sheet. 
 The missing data points were 27 (9.09%). 
 
Age of patients 
As Figure 3.1 below shows, of the male patients: 
 15.08% fell in the category ‘equal & older than 65 years’, and 
therefore fell in the intermediate-risk group; 
 8.41% fell in the category ‘younger than 30 years’; and 
 76.51% fell in the category ‘ equal & older than 30, but younger 
than 65, years’. 
 
The category of men ‘younger than 30 years’ was created because, in this 
category, false positive ETTs were found to be more prevalent than they were 






≥30<65 ( 137) 















Figure 3.1: Age of male patients 
 
As Figure 3.2 below shows, of the female patients: 
 14.40% fell in the category ‘equal & older than 65 years’, and 
therefore fell in the intermediate-risk group; 
 15.25% of women fell in the category ‘younger than 40 years’; 
and 
 70.33% of women fell in the category ‘equal & older than 40, but 
younger than 65, years’. 
 
The category of women ‘younger than 40 years’ was created, because in this 
category, false positive ETTs were found to be more prevalent than they were 
in the other categories.    
  
 
Figure 3.2: Age of female patients 
 
Diabetes status of patients 
As Figure 3.3 below shows, of the patients: 
 11.45% had diabetes, and therefore fell in the intermediate-risk 
group (10.78% non-insulin-dependent diabetes [NIDDM] + 0.67% 




≥40<65 ( 83) 















 72.38% did not have diabetes, and, depending on the other risk 
factors, might have fallen into the low-risk category. 
Of the charts, 16.17% had information missing, so that the diabetes status of 
the patients concerned was unknown. 
 
Figure 3.3: Diabetes status of patients 
 
IHD status of patients  
As Figure 3.4 below shows, of the patients: 
 13.8% had had previous IHD, and therefore fell in the 
intermediate-risk category; and 
 64.3% had had no previous IHD. 















Figure 3.4: IHD status of patients 
 
Individual risk factors of patients  
As Figure 3.5 below shows, of the patients: 
 32.32% (96) had hypertension, 53.19% (158) did not, and for 
14.47% (43) the relevant data points were incomplete; 
 33.33% (99) had a positive family history for IHD, 39.05% (116) 
had no positive history of IHD, and for 27.6% (82) the relevant 
data points were incomplete; 
 34.34% (102) were current smokers, 33.33% (99) did not smoke, 
18.85% (56) were ex-smokers, and for 13.46% (40) the relevant 
data points were incomplete; and 
 29.26% (88) responded positively for dyslipedaemia, 27.94% (83) 


















Figure 3.5: Individual risk factors of patients 
 
Patients with one or more risk factors 
In order to fall in the intermediate category, two or more risk factors were 
necessary. Of the patients with one or more risk factors (see Figure 3.6 
below): 
 37.71% (112) had one risk factor; 
 26.59% (79) had two risk factors; 
 11.11% (33) had three risk factors; 
 1.34% (4) had four risk factors; and 
 23.23% (69) had no risk factor. 
 
The missing data points in the audit of risk factors were as follows: 
 34.34% (102) had one missing data point 
 15.82% (47) had two missing data points; 
 5.7% (11) had three missing data points; and 



















Figure 3.6: Patients with one or more risk factors 
 
Changes in ECG while patients in ED 
The changes in the ECGs undertaken while the patient was in the ED on the 
presenting date revealed the following regarding the 297 charts reviewed: 
 290 ECGs were in sinus rhythm, and of the seven other charts: 
– two ECGs had not been performed; 
– four ECGs showed the presence of supraventricular 
tachycardia (SVT); and 
– one ECG was missing; 
 285 ECGs had no ST segment changes, and of the other 12 charts: 
– two ECGs had not been performed; 
– one ECG was missing; and 
– nine (including 4 SVT ECGs) had ST segment depression; 
 284 ECGs had narrow QRS complexes (<120ms; no inter- 
ventricular conduction delay, and of the other 13 charts: 
– two ECGs had not been performed; 
– one ECG was missing; and 














ECG having LBBB). 
 
Chronic renal disease 
Regarding chronic kidney disease, as estimated by GFR < 60ml/min: 
 GFR > 60ml/min = 236 patients (79.46%); 
 GFR < 60ml/min = 4 patients (1.34%); and 
 missing data = 57 patients (19.19%). 
 
Prior aspirin 
Regarding prior use of aspirin:  
 36 (12.12%) patients, all of whom had a history of IHD, were 
taking aspirin prior to the presenting date; 
 196 (65.99%) patients were not taking aspirin; and 




Regarding the undergoing of CXRs: 
 266 (89.56%) patients had undergone a CXR as part of the 
medical examination protocol. 
 19 (6.39%) patients had not undergone a CXR; and 
 there were 12 (4.04%) with missing data points. 
 
TNI testing 
The current protocol at Rockhampton Hospital for TNI and ACS workup 
requires at least two negative TNI tests: one on arrival and one preferably 
eight hours after the chest pain episode. This is in accordance with the 
recommendations of the 2006 Guidelines for the management of acute 
















Figure 3.7: Number of TNI tests per patient 
 
As Figure 3.7 above shows, of the patients: 
 2% had undergone no TNI blood test;  
 25% had undergone one TNI blood test; 
 58.5% had undergone two TNI blood tests; 
 14% had undergone three TNI blood tests; and 
 there were 0.5% with missing data points.  
 
Audit: time of TNI testing 
Table 3.2: Time from presenting in the ED to first TNI test (all 288 first TNI) 
 
 h: min: s 





*SD = standard deviation 
**Denotes blood taken by nursing staff and sent to the laboratory before the doctor had seen the 
















Table 3.3: Time from presenting in the ED to first TNI test (86 single TNI 
testing) 
 h: min: s 





*Denotes blood taken by nursing staff and sent to the laboratory before the doctor had seen the 
patient, or time of presentation not corrected on the EDIS computer program by the attending 
physician. 
 
The following findings were made regarding the 86 patients who 
underwent only a single TNI testing: 
 Four TNI tests were conducted eight or more hours after 
presenting. 
 82 patients underwent only one TNI test before the eight-hour 
protocol mark. (The timing of the test was in accordance with the 
time of presentation in the ED. Though it would have been better 
to use the time that the chest pain started, such information was 
too poorly noted on the patients’ charts to be of any value.)  
 
Table 3.4: Time from presenting in the ED to second TNI test  
 h: min: sec 





In respect of those patients who underwent a second TNI test: 
 In total, 202 (58.550% ) patients underwent a second TNI test, of 
which:  
– 48 (23.762%) underwent the second test after eight hours; 
and 














of the permissible minimum of eight hours.  
ETT 
Of the 297 charts reviewed: 
 28 ETTs were positive for IHD as follows: 
– There were 14 male and 14 female patients in this category. 
– The median age of the patients was 56.5 years.  
 The 28 ETTs were found to be as follows:  
– 12 MPSs, which were normal 
– 2 MPSs, which showed signs of prior IHD; 
– 5 patients, who had been admitted to the medical ward or to 
a CCU ward 
– 4 CA, which were normal; 
– 3 CA, which were abnormal; and 
– 3 with missing data. 
– Please note that one patient was both admitted and had a CA 
explaining the 29 tests/admissions for the 28 ETTs done. 
 The 75 equivocal ETTs were found to be as follows: 
– There were 47 male and 28 female patients. 
– The median age of the patients was 55 years. 
  The 75 ETTs were found to be as follows: 
– 41 MPSs, which were normal; 
– 14 MPSs, which showed signs of prior IHD; 
– 6 patients, who had been admitted to the medical ward or 
CCU; 
– 1 CA, which was normal; 
– 2 CAs, which were abnormal; and 
– 13 with missing data. 
– Please note that two patients were both admitted and had  
CAs explaining the 77 tests/admissions for the 75 ETTs done 
 In total (all risks): 
– 69 MPSs had been undertaken, of which 53 had presented as 
normal and 16 had shown signs of IHD (i.e. decreased left 














– 11 patient had been admitted to the medical ward or CCU; 
and 
– 10 CAs had been performed, of which 5 had shown 
abnormalities. 
 
 193 ETTs were negative: 
– There were 118 male and 75 female patients is this category. 
– The median age of the patients was 48 years. 
 
Low-risk category 
 Of the patients who had undergone ETTs, 143 (48.14%) fell into 
the low-risk category (as per the Queensland Health Guidelines), 
(Constantine [28]): 
– 13 ETTs were positive for IHD, which were found to be as 
follows: 
■ one MPS, which had shown signs of IHD; 
■ two patients, who were admitted to the medical ward or 
CCU, with one having a myocardial infarct; 
■ two CAs, which were normal; and 
■ two patients with an MPS booked, but whose results 
were not on the chart; and 
■ one with a missing data point. 
 There were 85 male, and 58 female, patients in this category. 
 The median age was 44 years. 
 The 28 ETTs that were equivocal for IHD were found to be as 
follows: 
– 18 MPSs, which were normal; 
– three MPSs, which showed signs of prior IHD; 
– one patient admitted to the medical ward or CCU; 
– one CA, which was normal; 
– two MPSs without results indicated on the charts; 















– one patient with a cardiac ultrasound scan; and 




 Of the patients, 154 (51.85%) who had ETTs fell into the 
intermediate-risk category, in respect of whom the following 
pertains: 
– There were 94 male and 60 female patients is this category. 
– The median age of patients was 56 years. 
– Eight ETTs were positive for IHD, which consisted of: 
■ two MPSs, which were normal; 
■ one MPS, which showed signs of prior IHD; 
■ three patients admitted to a medical ward or CCU (with 
one being admitted in Brisbane); 
■ two CAs conducted, of which one was normal and 
■ none with missing data points. 
– The median age for the group of patients with negative ETTs 
for IHD was 66 years. 13 of the group had had more tests 
done, consisting of: 
■ eight MPSs, which were normal; 
■ five 24-hour Holter rhythm monitors, of which one 
showed paroxysmal atrial fibrillation; 
■ one patient admitted to a medical ward or CCU; 
■ one patient with both a Holter and an MPS. 
– Of the ETTs, 36 were equivocal for IHD, consisting of: 
■ 21 normal MPSs; 
■ five MPSs, which showed signs of prior IHD; 
■ two 24-hour Holter rhythm monitors, which were 
normal; 
■ one patient admitted to a medical ward or CCU; 
■ one patient who underwent a cardiac ultrasound; 















■ three patients who underwent more than one test; 
■ one missing result; and 
■ one patient with a cardiac ischaemic event after the date 
of presentation, which was then audited (02-06-08). 
 
 
Relationship between the time of presenting and the date when the ETT 
was conducted 
The relationship between the time of presenting and the date when the ETT 
was conducted consisted of the following: 
 88 ETTs were done on the day of presentation to the ED; 
 107 ETTs were done the day following the presentation to the ED; 
 96 ETTs were done later; 
 The 88 ETTs done on the same day were carried out between 
00:00:00 and 15:30:00, with the median time for the period being 
09:32:30 (SD ±03:31:52). 
 Three of the patients with missing data points on their charts fell 
into this category. 
 
Survival after presentation to the ED and the subsequent ETT 
In terms of survival after presentation to the ED and the subsequent ETT: 
 None of the 297 patients could be found on the Queensland death 
register for the period 24-04-06 to 30-11-08. 
 Of the 297 questionnaires sent out, 116 (39.05%) were submitted 
on completion, with the 23 returned unanswered to the sender, and 
the 108 who failed to respond, amounting to 44.10% of the total. 
 Of the 116 who responded, 27 (23.27%) reported having 
experienced a chest pain episode of some sort after the event that 
had brought them to the ED in the first place. Of the 27 patients 
with post-event chest pain: 
– one had a myocardial infarct; 














– four had MPSs; 
– two had another ETT; and 
– one had a cardiac ultrasound. 
 On auditing the last dates found on Auslab and EDIS, the 
following was found: 
– 122 patients had dates entered into the systems after the date 
of the ETT. 
– The median for the period concerned was 213.5 days (with 
the SD being ±218.46 days). 
– The minimum period after the ETT was one day. 
– The maximum period after the ETT was 814 days. 
 
 
The following endpoints were measured: 
 Alive and well, with no signs or symptoms of IHD by date of 
follow-up contact, as follows: 
– 297 − (16+5+11+12) = 253(± 16 unknown patients) 
■ Total ETT – (Positive PMS + Positive CA + Admitted patients + Chest pain post 
ETT)  
 
 Alive, but with IHD that developed post-stress ECG by date of 
follow-up contact, as follows: 
– 27 out of 116 questionnaire replies showed recurring chest 
pain. 
– 12 out of the 27 had further investigations for ACS. 
 Death from IHD, as follows: nil (none for the period 2006-04-24 
to 2008-11-30). 
 Death from another cause, as follows: nil (none for the period  
24-04-06 to 30-11-08). 
No deaths were recorded in the death registry but I have to 
conceded that there is a possibility that some patient may have 
died in another State of the Commonwealth of Australia and there 
for not recorded in the Queensland registry. 














and had led to an MPS and/or angiography: 
– 28 ETT were positive and 75 equivocal for IHD (total: 103), 
with: 
■ MPS, with 16 positive, and 53 negative, for IHD; 
■ CA, with 5 positive, and 5 negative, for IHD; 
■ 11 admitted; and 



















When a patient presents to the Rockhampton ED complaining of chest pain, it 
is expected that the patient be treated according to the guidelines of 
Queensland Health (Constantine [28]). Once it has been decided that the 
patient has neither an ST segment elevation myocardial infarct (STEMI) nor 
non-ST segment elevation myocardial infarct (NSTEMI), or any other life-
threatening pathology, such as an aorta dissection or a pulmonary embolism, 
the patient must be risk stratified to enable the doctor concerned to develop 
the appropriate investigative strategy and treatment options. 
 
In Chapter 1 – Literature Review, the problems with risk stratification was 
already mentioned. These being:  
 Low diagnostic accuracy when diagnosis is based on ECG and 
clinical symptoms alone. 
 Chest pain of atypical distribution may indicate myocardial 
infarction. Up to a third of myocardial infarction patients may have 
atypical chest pain. 
 Less than half of those admitted with chest pain have ACS confirmed 
at discharge and up to 6% of those discharged have a missed 
myocardial infarction 
 Risk stratification is employed to improve diagnostic accuracy. There 
are many scores eg. TIMI, GRACE and PURSUIT, some better than 
others but all better than using an ECG and troponin at presentation 
alone.   
 
In Rockhampton ED, the patients classed as low-risk are supposed to be 
admitted to the ED Observation Unit (EDOU) to await the second TNI test, 
which should be conducted eight hours after the onset of pain. The patient is 
admitted to the observation unit so that an evolving myocardial infarction 
may be identified. Such identification is important, seeing that a study by 














an evolving myocardial infarct. Intermediate-risk and high-risk patients 
should not be admitted for ED observation, but should be referred medically 
for admittance to the medical ward or CCU. 
 
After the second negative TNI test, the patient should undergo an ETT (if 
physically possible) to conclude the cardiac examination and to identify the 
IHD. If the ETT is positive or equivocal, the patient must then progress to an 
MPS or to an angiography.  
 
One of the main findings of the audit is the poor compliance of the ED 
doctors with the prescribed guidelines on the management of chest pain. The 
finding will be discussed before assessing the primary objective of the study, 
namely the safety and efficacy of performing an early ETT on rural 
populations in the case of low-risk chest pain patients, to enable the selection 
of those who require admittance and further medical investigations.  
 
Chest pain data, particularly as regards the start and duration of such pain, 
were poorly documented. The poor documentation compromised both the 
timing of the TNI tests and the risk stratification. 
 
With regards to risk stratification, patients with the following risk factors fell 
into the intermediate-risk group and should have been admitted rather than 
being observed in EDOU and ETT, namely those: 
 65 years & older; 
 with diabetes; 
 with renal disease; 
 and with two or more of the following: 
– hypertension; 
– a family history of IHD; 
– a current habit of smoking; and 
– known dyslipidaemia. 
 
There was also a failure to perform necessary investigations, as can be seen 














 in respect of ECGs, the indefensible failure to record the 
conducting of any ECG in the case of two patients; 
 in respect of CXRs, the indefensible failure to perform a CXR on 
19 patients, so as to exclude alternative serious causes of chest 
pain, such as aortic dissection; and  
 in respect of TNI testing, the failure to follow the guidelines as to 
the time and quantity (two) of the tests required, which might have 
led to a failure to diagnose myocardial infarctions.  
 
All of the above failures to follow the appropriate guidelines were also 
compounded by very poor data recording. 
 
A large number of intermediate risk patients underwent EDOU admissions 
and ETT, which was contrary to the guidelines that recommend formal 
admittance and workup. The four patients with SVT were also 
inappropriately investigated and treated. 
 
The problems discussed above may have been due to a range of factors, 
including: ignorance, insufficient commitment to data collecting, and 
arrogance. 
 
In an interview, Dr Goodman expressed a belief that the main problem was 
that doctors do not like using risk stratification tables. 
We like to use our common sense in these matters – to look at a patient 
and make a decision – to use our heads over formulas. We have been 
taught that way. We like to think of medicine as an art rather than a 
science, and most doctors know what the guidelines are, but we don't 
take a standardize[d] approach to risk stratification at the bedside. I 
think it is very much the exception that risk scores are routinely 
applied. And this is a big part of why the wrong patients are getting 
referred for catheterization, or in the case of the audit for exercise 
















The efficacy and safety of the ETT performed in accordance with ED 
protocol prior to the discharge of a chest pain patient 
 
Efficacy 
Of the 28 positive ETTs, 13 fell in the low-risk group, 8 in the intermediate-
risk group and 7 in the high risk group. Positive ETT results were followed by 
more invasive testing, resulting in confirmation of ischaemia in 4 of the 
patients. The finding of false positive ETTs in the younger patients came as 
no surprise. However, the finding of a negative ETT in the younger group is 
useful, in that it makes ischaemia unlikely to have been the cause of the chest 
pain experienced. Despite this general rule, one patient in the younger group 
had a myocardial infarct. It is known that a small unstable plaque, which 
caused no ischaemia during the ETT, can, nevertheless, rupture and result in 
thrombosis. 
 
Of the 75 equivocal ETTs, 8 resulted in a diagnosis of ischaemia. Though the 
yield concerned was low, the patients concerned would have otherwise 
remained undiagnosed. Very importantly, those with a negative ETT were 
saved the cost, inconvenience and potential danger of more invasive testing. 
Of the patients with negative ETT, 13 underwent further investigations for 
reasons that were either unclear or unknown. 
 
 Safety  
No adverse events were reported as occurring during the ETT, even with 
those at intermediate risk. No deaths among the study group were recorded in 
the Queensland death register up to November 2008.  
 
A more detailed discussion of the individual data points and their outcome is 
presented below. 
 
4.1 Chest pain 
The data in terms of chest pain category (consisting of duration, frequency, 
and pain-free at presentation) were very badly noted on the charts.There is a 














of pain and the 9.09% missing data points for pain-free on arrival at the ED. 
This is due to the fact that it could be deduced from the nursing observation 
sheet (on which the first observations are recorded on arrival) whether or not 
the patient was pain-free. The attending doctors’ notes had to be relied on for 
the duration of chest pain which, as indicated by the almost 50% missing data 
points, were very poorly recorded on the patients’ charts. 
 
4.2 Age 
Of the patients, 15% (27) of the men and 14.4% (17) of the women were 
older than 65 years. Such patients automatically fell into the intermediate-risk 
category, and should have been admitted to the medical ward, and not to the 
EDOU. 
 
Of the patients, 8.37% of the men were younger than 30 years old, and 
15.25% of the women were younger than 40 years old, so that the ETT was 
more likely to give false than true positive values (Hill [58]). 
 
If risk profiles of younger patients are strongly suggestive of IHD, it might be 
better, from the start, to use tests that tend to give fewer false values, such as 
cardiac ultrasound and/or MPS.  
 
4.3 Diabetes and IHD 
 
Of the patients, 11.45% had diabetes and 13.8% had prior IHD, so that they 
fell into the intermediate-risk group, members of whom should not have gone 
to the EDOU, and on to the ETT pathway, but who should rather have been 
admitted to the medical ward. A concern here is that 16.16% of diabetic 
patients and 21.89% of IHD patients did not have the appropriate data points 
evaluated. Of the patients, 4.04% (12) had both diabetes and IHD, so that 
they should also have been admitted by medical team. 
 
4.4 Hypertension, positive family history of IHD, current smoking 
habits, and dyslipidaemia. 














intermediate-risk categories: hypertension, a positive family history of IHD, 
current smoking habits, and dyslipidaemia. The details of such patients were 
also particularly badly noted on the charts, with the number of missing data 
points being as follows: 
 14.47% for those patients with hypertension; 
 27.6% for those patients with a positive family history of IHD; 
 13.46% for those patients with a current smoking habit; and 
 42.42% for those with dyslipidaemia. 
Of the patients, only 37% (120) had all four data points complete, and had 
therefore been correctly evaluated respecting the data points. 
 
Nevertheless, of the patients there were 39.05% (116) with two or more of the 
risk factors, (of which 26.59% [79] had two; 11.11% [33] had three; and 
















Of concern in this category were two patients who did not have an ECG done 
for the evaluation of chest pain. It was also noted that four patients with SVTs 
were sent to the EDOU for observation, serial TNIs, ECGs and ETT, despite 
the absence of ischaemia. Although IHD can cause arrhythmias and ETT, 
according to Hill and Timmis (Hill [58]), it can be used as an aid for 
diagnosing arrhythmias, so that such patients might benefit more from going 
the medial route, since most SVTs are not caused by IHD. The EDOU serial 
pathway is mainly for ruling out ACS in patients, rather than for the 
evaluation of arrhythmias. 
 
4.6 Renal disease, prior aspirin use, and CXR 
Four patients, who should have gone on the medical pathway, had GFR 
< 60 ml/min. All those patients who had previous IHD had prior aspirin use, 
as was to have been expected. Aspirin usage (75 mg to 100 mg) is 
recommended in the 2006 guidelines for the management of ACSs 
(Constantine [28]). 
 
CXRs are done to exclude other possible causes of chest pain. A total of 
6.39% (19) patients did not undergo a CXR and 4.04% (12) of the data points 
were missing. The concern, again, is that other possible causes of chest pain 
might be overlooked. 
 
4.7 TNI, time and pain 
According to the guidelines for the management of ACSs, the TNI level 
should be checked on arrival. The rationale is that a rise in TNI levels 
indicates the presence of myocardial necrosis, which is a high-risk feature in 
NSTSEACS.  
 
TNI is the preferred marker, because about a third of patients with elevated 
TNI, but with normal creatinin kinase (CK) and CK-MB levels, are likely to 
develop an adverse outcome. TNI testing should be repeated eight hours or 














insufficiency, if the testing is initially negative. The rationale behind the 
repeat test is that TNI elevation is often delayed by four to six hours; 
therefore, repeat TNI testing is necessary for identifying patients at high risk 
who might benefit from aggressive therapy and early invasive strategy 
(Constantine [28]). 
 
None of the patients had a positive TNI test, which would have placed them 
in the high-risk category. It is, however, of concern that 2.36% (7) of the 
patients had no TNI level assessment performed, with 28.96% undergoing 
only one assessment. The median time for the testing of all first TNI levels 
was 41 minutes from arrival to result, according to the Auslab pathology 
computer system. Such a median time may be acceptable if the time it took to 
assess the patient, to obtain the initial ECG and set of observations, and to 
obtain the blood sample, as well as to label it and to send it to the laboratory, 
is taken into account. 
 
However, the SD of 2 hours and 32 minutes means that the blood sample 
could have been taken well before/after the 41 median minutes after arrival. It 
has to be noted that some values were negative, indicating that the blood 
sample was taken before the doctor had seen the patient. The timing of such 
blood samples has two possible explanations: 
 The attending nurse took the blood sample, and recorded the ECG 
during the initial assessment, before the doctor had seen the 
patient. 
 The attending doctor saw the patient on arrival and did not enter 
the details of the consult immediately onto the EDIS computer 
system. When, finally, the doctor did log onto the computer 
management program, the time of logging in was not corrected to 
indicate that of the consultation. 
From personal observation, it is clear that both the above situations tend to 
occur. However, it is beyond the scope of the current audit to evaluate the 
practice and the influence thereof. 
 














pain occurred at least eight hours before the arrival of the patient at the ED, 
provided that the patient has been pain-free for the intervening period. Of the 
patients who had only one TNI level tested, four TNI levels were tested eight 
hours after the patient had first presented to the ED, and 84 were conducted 
before eight hours had elapsed. The median time for the ‘once only’ TNIs was 
a concerning 47 minutes (with the SD being 2 hours and 44 minutes). Clearly, 
not all of the 84 patients fell into the category described at the outset of the 
paragraph; therefore, at least some of them were at risk of having an evolving 
myocardial infarct, which would not have been detected. 
 
Miller et al. [77] alleviate some of the fear of missing an evolving myocardial 
infarction, saying: 
...our results show that on the whole emergency physicians are doing a 
good job in picking up the patients with evolving myocardial infarction 
before conclusive Troponin tests are in. It was hard to tell from this 
study which factors are the most important in identifying these patients. 
It was a combination of findings from the patient's history, clinical 
examination, and ECG. But what we have shown is that the emergency 
doctor’s best guess is usually right in finding the patients. 
 
Observing the patient for a period of eight hours prior to the start of the 
second TNI test after the last episode of chest pain is necessary. In the current 
study, such a period of observation is extremely problematic to evaluate, due 
to the bad notation of the time and of the duration and frequency of pain by 
the attending doctors on the patients’ charts. 
 
Of the patients in the current study, 53.19% (158) had pain on arrival. 
 
With 202 second TNI tests being undertaken, 68.10% of the patients 
underwent a second TNI test, though only 48 (16.16%) of the tests were 
performed eight hours after the patient first presented to the ED.  
 
The duration of pain had a median length of 45 minutes (with SD of 702.15 














features include presentation with clinical features consistent with those of 
ACS and repetitive or prolonged (> 10 min) ongoing chest pain or 
discomfort. 
 
The 145 patients who had chest pain (presumed to be ischaemic) for longer 
than ten minutes fell into the high-risk category and should have been 
admitted to a CCU, which clearly did not happen. The reason for this might 
be that the attending doctors could have had different understandings of the 
clinical features of ACS. 
 
Although the clinical features of ACS are taught in the first years of clinical 
practice, Lee et al. [79] found that doctors tend to risk stratify incorrectly, 
tending to underestimate the risk concerned, and, therefore, not sending their 
patients for PCI. In their study, 35.3% (753) of patients were not referred for 
catheterisation, though 51.1% (305) of them were found to have had 
intermediate or high TIMI scores on review of their classification, so that they 
should have been considered for catheterisation. 
 
4.8 ETT 
The EDOU pathway was considered to be suitable for low-risk patients, as 
defined by the Queensland Health guides, but the current audit discovered 
that more (namely 155 or 52.18%) intermediate-risk patients were on it than 
were low-risk patients (comprising 142 or 47.81% of the total). The low-risk 
category delivers more positive ETTs than does the intermediate-risk category 
at 9.15% (compared with 5.16% of the intermediate category). The low-risk 
category also contained one myocardial infarction. 
 
One reason why the low-risk category might have contained more positive 
ETTs is that the group concerned tended to consist of men below 30 years in 
age and women below 40 years in age (with the median age being 44 years). 
As we know from Hill and Timmis (Hill [58]), these age groups have a 
tendency to indicate false positive tests. 
 














negative ETT, were, nevertheless, found to have undergone other cardiac 
tests. In the group, eight MPSs and five 24-hour Holter monitoring were 
recorded, with one patient being noted as having undergone both. The cardiac 
examination for the patients concerned should have ended with the negative 
ETT. The reason why the doctors continued with the testing in such cases is 
unknown, though it might have been that the risk stratification was incorrect. 
 
The 88 ETTs that were done on the same day showed that presentations to the 
ED between 00:00 and 15:00 underwent their ETT on the same day, due to 
the working hours of the CM units. 
 
4.9 Conclusion 
The Queensland death register recorded no deaths for any of the 297 patients 
whose charts were audited (concluding in November 2008). However, it must 
be noted that Australia’s other states and territories have their own death 
registers, and that only the Queensland death register was evaluated. Of the 
297 patients, 27 had a further episode of chest pain, one of which was a 
myocardial infarction. In addition, four had CAs and four had an MPS. 
 
122 (41.07%) patients had entries on the Auslab and/or EDIS computer 
databases after the ETT. The median time period after the ETT was 213.5 
days, with an SD of ±218.5 days, and with a maximum period of 814 days. 
 
In response to the question (included in the questionnaire) “How did you rate 
the whole process of being assessed for your pain?”, 85 (73.27%) of the patients 
rated the process as 5 (very good), 18 (15.51%) rated it as 4 (good), three 
rated it as 1 (poor), and 3 did not grade the process. It would, therefore, seem 
















CONCLUSION & RECOMMENDATIONS 
 
5.1 Conclusion 
The audit revealed poor practice and tardiness in respect of following the applicable 
guidelines, as well as very poor documentation. Despite this, the ETT seemed to be a 
reasonably safe practice in the specified setting, even in the case of intermediate-risk 
patients. The ETT helped to identify some patients who needed further investigation 
for possible IHD.  
 
However, the ETT did not prevent 27 patients from representing to the ED with 
further episodes of chest pain. The false positive ETTs found were to have been 
expected, particularly among the younger patients. 
 
5.2 Recommendations 
The following recommendations pertain in respect of the current study: 
1) Education of emergency room doctors 
Doctors need to be better educated about what constitutes typical ischaemic 
chest pain, the risk factors of ACS, risk stratification, and the importance of 
documentation. Specific attention should be given to education of 
international medical graduates to improve their understanding of the 
applicable guidelines and in the correct way in which to process risk 
stratification, as well as to overcome any language and cultural 
misunderstandings/problems. 
 
2) Following of guidelines  
All medical (from other departments e.g. Medical) and nursing staff should be 
made aware of the importance of following the appropriate guidelines. 
 
3) Use of tick sheets  
Tick sheets should be used to encourage conformity with the prescribed 















4) Consideration of the instituting of critical care pathways 
Consideration should be given to the institution of critical care pathways for 
those patients at high risk for ACS. 
 
5) Continuation and improvement of early ETT  
The continuation and improvement of the practice of conducting early ETTs 
with patients at risk should be carefully considered, with appropriate referral 
for those with positive and equivocal tests. The continuing use of ETT in 
selected intermediate-risk patients who have normal ECGs and negative TNI 
should also receive careful consideration, in order to alleviate the burden on 
the medical department and to serve as a cost-saving measure. 
 
6) Admittance of patients to the hospital 
If any doubt exists, patients should be admitted to the hospital. Such a step 
needs to be clear in the guidelines, and should be agreed on in conjunction 
with the medical department. 
 
7) Repetition of audit  
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a. ROCKHAMPTON HEALTH SERVICE DISTRICT 
 
Enquiries to: Sue Davey 
Telephone: 07 4920 7044 
Facsimile: 07 4920 7249 
Email: 
 Our Ref: «UR_No» 
 











You have visited the Rockhampton Emergency Department and we arranged some 
investigations for chest pain.  You had an exercise stress test carried out on 
«TEST_DATE». 
 
We are evaluating the outcome of this visit and tests carried out so that we can 
continue to provide the optimum care for patients. 
 
Will it be possible for you to answer the following questions and send it back in the 
enclosed envelope on or before 22 January 2009? 
 







Dr Henk Siglé 
























If yes: did you have a heart attack/ angiogram/myocardial perfusion scan/other ______________ 
 
 How did you rate the whole process of being assessed for your pain? 
 
Excellent   5   4   3   2   1   Poor   (with 5 being very good and positive and one being poor and negative) 
 
Once again, thank you for your help in completing these questions.  This feedback is very helpful for us 







Dr Henk Siglé 











































Age, separate points for 
enrolment diagnosis 
Decade [UA (MI)] 
50     8 (11) 
60     9 (12) 
70     11 (13) 
80     12 (14) 
Gender 
Male     1 
Female    0 
Worst CCS class in previous 6 weeks 
No angina or CCS I/II  0 
CCS III/IV    2 
Signs of heart failure   2 




Age 65 years     1 
≥ 3 risk factors for CAD   1 
Use of ASA (last 7 days)   1 
Known CAD (stenosis 50%)   1 
> 1 episode rest angina in 24 hrs  1 
ST segment deviation    1 





< 40      0 
40–49      18 
50–59      36 
60–69      55 
70–79      73 
≥ 80      91 
Heart rate (bpm) 
< 70      0 
70–89      7 
90–109     13 
110–149     23 
150–199     36 
> 200      46 
Systolic BP (mmHg) 
< 80      63 
80–99      58 
















120–139     37 
140–159     26 
160–199     11 
> 200      0 
Creatinine (mg/dl) 
0–0.39      2 
0.4–0.79     5 
0.8–1.19     8 
1.2–1.59     11 
1.6–1.99     14 
2–3.99      23 
> 4      31 
Killip class 
Class I     0 
Class II     21 
Class III     43 
Class IV     64 
Cardiac arrest at admission   43 
Elevated cardiac markers   15 
ST segment deviation   30 
*P de Araujo Conçalves et al. “TIMI, PURSUIT, and GRACE risk scores: Sustained prognostic value and interaction with 
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Dear Dr Sigle 
Health Sci""""" Faculty 
R~eal'Ch Ethics Committee 
Room E52-24 Groote Schuur Hospital Old Main Building 
Observatory 7925 
Telephone [021[4066338 • Facsimile [021] 4066411 
e-mail: shurctta.thnma<@ucr.ac.» 
PROJECT TITLE, USE OF STRESS EeG IN EMERGENCY DEPARTMENT TO ASSESS LOW 
RISK PATIENTS WITH SUSPECTED CORONARY SYNDROME 
Thank you for submitting your stud), to the Research Ethics Committee for review. 
It is a pleasure 1:<> in[Qt\n you that the Ethics Committee has ronnally appcoved the above-mentioned study. 
Approval is granted for one year till the 10 December 2009. 
Please submit ao annual progress report if the research continue, beyond tbe expiry <hle_ Please submit a brief 
SllIIlIllitry of findings if you complete the study within the approval period so that we eiUl. close om fik 
Please note <hat the ongoing ethical conduct of the study remains the responsibility of the principal 
investigator. 
Please quote the REC. REF in all yow- correspondence. 
Yours ,incerely 
PROFESSOR M BLOCKMAN ff CHAIRPERSON· HSF HUMAN ETHICS 
F edernl Wide Assurance Number: f'\1:r AOOOO1637. 
Institutional Re,':iew Board (lRD) number. IRBOOOO1933 
Thi. 'erves ttl confirm <hat the University of Cape TowIl Research Ethics Committee complies {O the Ethics 

















SA), I-'ood and Drug l\dmlmstratton (I-'DA-USA), International Convention on Hannorusanon Good Clm.tcal 
P~actice (lCH GCP) and Declaration of Helsinki guidelines. 
The Rtsoarch Ethics Committee granting this approval is in compliance with the ICH H attn<mised T ripartitc 
Guidelines E6: Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95) and FDA Code Federal 
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Dr HM Sigle has permission to audit the charts of patients who had Stress ECG's via the 
Emergency Department at the Rockhampton Base Hospital as well as to conduct a 
questionnaire in relation to these Stress ECG's. 





Director - Emergency Department 
Rockhampton Base Hospital 
Tel: 0749207570 
Mob: 0438716689 / 0488766400 
Email : peter_thompson@health.qld.gov.au 
Office 
Director of Emergency Department 




Rockhampton Q 4700 
Phone 
49207570 
Fax 
49207249 
